The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
Open accessAbstract
Resveratrol, a polyphenol found in red wine, peanuts, soy beans, and pomegranates, possesses a wide range of biological effects. Since resveratrol’s properties seem ideal for treating neurodegenerative diseases, its ability to diminish amyloid plaques was tested. Mice were fed clinically feasible dosages of resveratrol for forty-five days. Neither resveratrol nor its conjugated metabolites were detectable in brain. Nevertheless, resveratrol diminished plaque formation in a region specific manner. The largest reductions in the percent area occupied by plaques were observed in medial cortex (−48%), striatum (−89%) and hypothalamus (−90%). The changes occurred without detectable activation of SIRT-1 or alterations in APP processing. However, brain glutathione declined 21% and brain cysteine increased 54%. The increased cysteine and decreased glutathione may be linked to the diminished plaque formation. This study supports the concept that onset of neurodegenerative disease may be delayed or mitigated with use of dietary chemo-preventive agents that protect against β-amyloid induced neuronal damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“A bioavailable Cu/Zn chelator decreases brain amyloid-β deposition by 49% (Cherny et al., 2001).”
BackgroundExcess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Self-citationChishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Self-citationInhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 779
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
Resveratrol stimulates AMP kinase activity in neurons
Dasgupta, B., & Milbrandt, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610068104 · Cited by 723
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678
Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications
Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., & Gibson, G. E. (2005) · Annals of Neurology · doi:10.1002/ana.20474 · Cited by 622
Self-citationResveratrol protects against global cerebral ischemic injury in gerbils
Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, A., Lubahn, D., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 527
Butterfield, D. A., Hensley, K., Harris, M., Mattson, M., & Carney, J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1508 · Cited by 404
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
Jang, J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 390
Inhibition of cancer growth by resveratrol is related to its low bioavailability
Asensi, M., Medina, I., Ortega, A., Carretero, J., Baño, M. C., Obrador, E., & Estrela, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00911-5 · Cited by 388
Pappolla, M. A., Chyan, Y., Omar, R. A., Hsiao, K., Perry, G. L., Smith, M. A., & Bozner, P. (1998) · Europe PMC (PubMed Central) · Cited by 365
Pratic�, D., Clark, C. M., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<809::aid-ana19>3.0.co;2-9 · Cited by 348
Frémont, L., Belguendouz, L., & Delpal, S. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00209-x · Cited by 333
Human, Rat, and Mouse Metabolism of Resveratrol
Yu, C., Shin, Y. G., Chow, A., Li, Y., Kosmeder, J. W., Lee, Y. S., Hirschelman, W. H., Pezzuto, J. M., Mehta, R. G., & van Breemen, R. B. (2002) · Pharmaceutical Research · doi:10.1023/a:1021414129280 · Cited by 319
Beckman, K. B., & Ames, B. N. (2000) · Handbook of Oxidants and Antioxidants in Exercise · doi:10.1016/b978-044482650-3/50027-4 · Cited by 307
Belguendouz, L., Fremont, L., & Linard, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00820-9 · Cited by 299
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
Li, F., Calingasan, N. Y., Yu, F., Mauck, W. M., Toidze, M., Almeida, C. G., Takahashi, R. H., Carlson, G. A., Flint Beal, M., Lin, M. T., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02455.x · Cited by 276
Resveratrol Is Absorbed in the Small Intestine as Resveratrol Glucuronide
Kuhnle, G., Spencer, J. P. E., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K. S., Rice-Evans, C., & Hahn, U. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2750 · Cited by 249
LI, Y., CAO, Z., & ZHU, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.08.002 · Cited by 235
Nathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K., Fuortes, M., Lin, M., Ehrt, S., Kwon, N. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051529 · Cited by 214
Self-citationOxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 195
F4 ‐ Isoprostanes as Specific Marker of Docosahexaenoic Acid Peroxidation in Alzheimer's Disease
Nourooz‐Zadeh, J., Liu, E. H. C., Yhlen, B., Änggåard, E. E., & Halliwell, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720734.x · Cited by 187
Alzheimer’s disease and oxygen radicals: new insights
Praticò, D. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00919-4 · Cited by 186
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
Gibson, G. E., Haroutunian, V. H., Zhang, H., Park, L. C. H., Shi, Q., LESSER, M. L., Mohs, R. C., Sheu, R., & Blass, J. P. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3<297::aid-ana3>3.0.co;2-z · Cited by 184
Self-citationGibson, G. E., Blass, J. P., Beal, M. F., & Bunik, V. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:043 · Cited by 179
Self-citationHallman, P., PERRIN, D. D., & Watt, A. E. (1971) · Biochemical Journal · doi:10.1042/bj1210549 · Cited by 174
Lakritz, J., Plopper, C. G., & Buckpitt, A. R. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2032 · Cited by 165
Sale, S., Tunstall, R. G., Ruparelia, K. C., Potter, G. A., Steward, W. P., & Gescher, A. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20884 · Cited by 165
Some Metal Complexes of Sulfur-containing Amino Acids1,2
Li, N. C., & Manning, R. A. (1955) · Journal of the American Chemical Society · doi:10.1021/ja01625a006 · Cited by 165
Mitochondrial respiratory chain activity in the human brain as a function of age
Ojaimi, J., Masters, C. L., Opeskin, K., McKelvie, P., & Byrne, E. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00071-8 · Cited by 159
Karuppagounder, S. S., Xu, H., Shi, Q., Chen, L. H., Pedrini, S., Pechman, D., Baker, H., Beal, M. F., Gandy, S., & Gibson, G. E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.013 · Cited by 155
Self-citationRobb, E. L., Page, M. M., Wiens, B. E., & Stuart, J. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.138 · Cited by 147
Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin
Conte, A., Pellegrini, S., & Tagliazucchi, D. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.08.001 · Cited by 131
Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits
Wilson, T. E., Knight, T. J., Beitz, D. C., Lewis, D. S., & Engen, R. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00260-3 · Cited by 117
Antioxidant activity of resveratrol in red wine
Miller, N. J., & Rice-Evans, C. A. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1789 · Cited by 115
The Effect of Aging on Glutathione and Cysteine Levels in Different Regions of the Mouse Brain
Chen, T. S., Richie, J. P., & Lang, C. A. (1989) · Experimental Biology and Medicine · doi:10.3181/00379727-190-42879 · Cited by 111
Pharmacologic Role of Cysteine in Ameliorating or Exacerbating Mineral Toxicities
Baker, D. H., & Czarnecki-Maulden, G. L. (1987) · Journal of Nutrition · doi:10.1093/jn/117.6.1003 · Cited by 110
Olivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, H. B., Brockhaus, M., & Brack, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00090.x · Cited by 99
Determination of trans-Resveratrol in Plasma by HPLC
Juan, M. E., Lamuela-Raventós, R. M., de la Torre-Boronat, M. C., & Planas, J. M. (1999) · Analytical Chemistry · doi:10.1021/ac9808831 · Cited by 91
Zinc toxicity on neonatal cortical neurons: involvement of glutathione chelation
Chen, C., & Liao, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01691.x · Cited by 79
Protective Effects of Piceatannol against Beta‐Amyloid–Induced Neuronal Cell Death
Kim, H. J., Lee, K. W., & Lee, H. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.051 · Cited by 75
Karuppagounder, S. S., Shi, Q., Xu, H., & Gibson, G. E. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.01.011 · Cited by 58
Self-citationPinto, J. T., Raamsdonk, J. M. V., Leavitt, B. R., Hayden, M. R., Jeitner, T. M., Thaler, H. T., Krasnikov, B. F., & Cooper, A. J. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03255.x · Cited by 57
Self-citationAlpha1-antitrypsin activity in subarachnoid hemorrhage
Tartara, F., Gaetani, P., Tancioni, F., Guagliano, A., Klersy, C., Forlino, A., Marzatico, F., & y Baena, R. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00263-9 · Cited by 35
Resveratrol and Its Glycon Piceid Are Stable Polyphenols
Prokop, J., Abrman, P., Seligson, A. L., & Sovák, M. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.11 · Cited by 33
Studer, R. O., Baysang, G., & Brack, C. (2001) · Biogerontology · doi:10.1023/a:1010065103073 · Cited by 28
Stability of resveratrol over time and in the various stages of grape transformation.
Bertelli, A. A. E., Gozzini, A., Stradi, R., Stella, S., & Bertelli, A. A. A. (1998) · PubMed · Cited by 21
Çakır, S., Biçer, E., & Eleman, A. (2001) · Transition Metal Chemistry · doi:10.1023/a:1007119907894 · Cited by 20
Cited by
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., Reynolds, B. A., Brewer, J. B., Rissman, R. A., Raman, R., Aisen, P. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002035 · Cited by 736
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 645
Small molecule SIRT1 activators for the treatment of aging and age-related diseases
Hubbard, B. P., & Sinclair, D. A. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.12.004 · Cited by 569
Metadata
- Authors
- Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.-L., Beal, M. F., & Gibson, G. E.
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 54
- Issue
- 2
- Pages
- 111-118
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W2094789916
- Cited by
- 485
- References
- 61
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.